Seguir
Jun Yu
Jun Yu
Tianjin Medical University Cancer Institute and Hospital
Dirección de correo verificada de tjmuch.com
Título
Citado por
Citado por
Año
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia
M Kanda, H Matthaei, J Wu, SM Hong, J Yu, M Borges, RH Hruban, ...
Gastroenterology 142 (4), 730-733. e9, 2012
8192012
ATM Mutations in Patients with Hereditary Pancreatic Cancer
NJ Roberts, Y Jiao, J Yu, L Kopelovich, GM Petersen, ML Bondy, ...
Cancer discovery 2 (1), 41-46, 2012
5732012
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
T Moriyama, K Ohuchida, K Mizumoto, J Yu, N Sato, T Nabae, S Takahata, ...
Molecular cancer therapeutics 8 (5), 1067-1074, 2009
4072009
Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma
K Shindo, J Yu, M Suenaga, S Fesharakizadeh, C Cho, A Macgregor-Das, ...
Journal of Clinical Oncology 35 (30), 3382-3390, 2017
4012017
Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection
G Gemenetzis, VP Groot, AB Blair, DA Laheru, L Zheng, AK Narang, ...
Annals of surgery 270 (2), 340-347, 2019
3562019
Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
E Amato, M Molin, A Mafficini, J Yu, G Malleo, B Rusev, M Fassan, ...
The Journal of pathology 233 (3), 217-227, 2014
3472014
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ...
Nature 486 (7402), 266-270, 2012
3432012
MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls
A Li, J Yu, H Kim, CL Wolfgang, MI Canto, RH Hruban, M Goggins
Clinical cancer research 19 (13), 3600-3610, 2013
3422013
MicroRNA alterations of pancreatic intraepithelial neoplasias
J Yu, A Li, SM Hong, RH Hruban, M Goggins
Clinical cancer research 18 (4), 981-992, 2012
2812012
Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma
VP Groot, G Gemenetzis, AB Blair, RJ Rivero-Soto, J Yu, AA Javed, ...
Annals of surgery 269 (6), 1154-1162, 2019
2612019
MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell …
J Yu, K Ohuchida, K Mizumoto, N Sato, T Kayashima, H Fujita, K Nakata, ...
Molecular cancer 9, 1-10, 2010
2402010
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins
Gut 64 (11), 1783-1789, 2015
2262015
Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
H Fujita, K Ohuchida, K Mizumoto, S Itaba, T Ito, K Nakata, J Yu, ...
Neoplasia 12 (10), 807-IN8, 2010
1912010
International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
AJ Scott, JL Alexander, CA Merrifield, D Cunningham, C Jobin, R Brown, ...
Gut 68 (9), 1624-1632, 2019
1682019
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal …
J Yu, Y Sadakari, K Shindo, M Suenaga, A Brant, JAN Almario, M Borges, ...
Gut 66 (9), 1677-1687, 2017
1652017
Genetic analyses of isolated high‐grade pancreatic intraepithelial neoplasia (HG‐PanIN) reveal paucity of alterations in TP53 and SMAD4
W Hosoda, P Chianchiano, JF Griffin, ME Pittman, LAA Brosens, M Noë, ...
The Journal of pathology 242 (1), 16-23, 2017
1502017
MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion
J Yu, K Ohuchida, K Mizumoto, H Fujita, K Nakata, M Tanaka
Cancer biology & therapy 10 (8), 748-757, 2010
1472010
Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer
S Ohhashi, K Ohuchida, K Mizumoto, H Fujita, T Egami, J Yu, H Toma, ...
Anticancer research 28 (4B), 2205-2212, 2008
1462008
MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma
N Ikenaga, K Ohuchida, K Mizumoto, J Yu, T Kayashima, H Sakai, H Fujita, ...
Annals of surgical oncology 17, 3120-3128, 2010
1412010
Circulating tumor DNA as a clinical test in resected pancreatic cancer
VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ...
Clinical Cancer Research 25 (16), 4973-4984, 2019
1402019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20